Diabetes Risk by Age Group – When to Get Tested

Diabetes risk rises sharply with age, but it is not exclusive to older adults. Adults 45 and older face the highest baseline risk and should begin routine screening immediately, while people as young as 35 with one or more risk factors qualify for earlier testing under current U.S. guidelines. The three major forms of diabetes, Type 1, Type 2, and gestational, each peak at different life stages, making age-specific awareness the single most actionable factor in catching the disease early.

Approximately 37.3 million Americans currently live with diabetes, and an additional 96 million have prediabetes, a condition where blood glucose levels are elevated but not yet high enough to meet the full diagnostic threshold for Type 2 diabetes. The total economic cost of diagnosed diabetes in the United States reached $327 billion, encompassing $237 billion in direct medical costs and $90 billion in reduced productivity. These figures make prevention and early detection not merely a personal health priority but a national economic one.

How Age Shapes Your Odds of Developing Diabetes

Diabetes risk is not static; it shifts meaningfully at specific life stages, making age one of the most reliable predictors clinicians use. The American Diabetes Association (ADA) recommends that all adults begin screening at age 35 if overweight or obese, and at age 45 for everyone regardless of weight.

The risk pattern does not simply climb in a straight line from youth to old age. Several distinct biological and behavioral inflection points appear at ages 10 to 18, 35, 45, and 65, each representing a window where screening or lifestyle intervention delivers the most measurable benefit.

Beyond age alone, diabetes exists across three primary classifications that behave differently across the lifespan. Type 1 diabetes is an autoimmune disease where the immune system destroys insulin-producing beta cells, requiring lifelong insulin therapy and appearing most often in childhood or young adulthood. Type 2 diabetes develops when cells become resistant to insulin and the pancreas cannot compensate with sufficient production, making it the form most strongly linked to age, weight, and lifestyle. Gestational diabetes emerges during pregnancy and resolves after delivery but leaves lasting metabolic consequences for both mother and child.

Key Finding: The U.S. Preventive Services Task Force (USPSTF) recommends screening for prediabetes and Type 2 diabetes in adults aged 35 to 70 who are overweight or obese, confirming that the risk conversation starts well before retirement age.

Childhood and Adolescence: Ages 10 to 17

Children and teenagers carry real diabetes risk, and the type of diabetes most likely to appear differs fundamentally from adult-onset disease. Type 1 diabetes, an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas, most commonly appears between ages 4 and 14, with a notable surge around puberty onset at approximately age 10 to 12.

Type 2 diabetes in youth, once considered rare, has risen dramatically alongside pediatric obesity rates in the United States. The CDC reports that Type 2 diabetes diagnoses in people under 20 increased by roughly 95 percent between 2001 and 2017. Youth who are overweight, physically inactive, or who have a first-degree relative with Type 2 diabetes face the highest exposure within this group.

The SEARCH for Diabetes in Youth Study

The SEARCH for Diabetes in Youth study, a multi-site surveillance program funded by the CDC and the National Institutes of Health (NIH), is the most comprehensive source of pediatric diabetes data in the United States. It tracks new cases across five racially and ethnically diverse study sites in California, Colorado, Ohio, South Carolina, and Washington state.

SEARCH data confirm that Type 1 diabetes incidence is rising at approximately 1.9 percent per year in U.S. youth, while Type 2 diabetes incidence among youth rose 4.8 percent annually between 2002 and 2015, with the steepest increases seen in American Indian, Black, and Hispanic youth.

The TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) trial, a landmark NIH-funded clinical trial, found that nearly half of youth with Type 2 diabetes experienced treatment failure within a few years of diagnosis, and complications including kidney disease and nerve damage appeared much earlier than in adults with the same diagnosis. Youth-onset Type 2 diabetes is more aggressive than adult-onset Type 2 diabetes, making early identification more consequential in this group than in any other.

Distinguishing Type 1 from Type 2 in Young People

Clinicians sometimes face genuine diagnostic difficulty separating Type 1 from Type 2 in overweight teenagers, because both conditions can present similarly. Key distinguishing tools include:

• C-peptide testing: C-peptide is a byproduct of insulin production. Low or absent C-peptide strongly suggests Type 1 diabetes, since the beta cells producing insulin have been destroyed.
• Autoantibody testing: The presence of specific autoantibodies, including islet cell antibodies, glutamic acid decarboxylase antibodies (GAD65), and insulin autoantibodies, confirms the autoimmune mechanism of Type 1 diabetes.
• Ketone levels at diagnosis: Diabetic ketoacidosis (DKA), a dangerous state where the body breaks down fat for fuel and produces acidic ketone bodies, is far more common at Type 1 onset than Type 2 onset.

Misclassification carries real consequences. A teenager incorrectly treated for Type 2 when they actually have Type 1 may be placed on oral medications instead of insulin, leading to preventable DKA hospitalizations.

Screening Criteria for Children and Teens

Children meeting two or more of these criteria should be tested beginning at age 10 or at the onset of puberty, whichever comes first, and retested every 3 years if results are normal.

An age calculator is a handy online tool that calculates the current age of a person based on a given date and year.

The 20s and 30s: A Decade Often Missed by Screening

Adults in their 20s and early 30s are the least-screened group in the United States despite carrying accumulating biological risk that will not become visible until their 40s. Prediabetes can be present for up to 10 years before a formal Type 2 diabetes diagnosis, meaning the biological clock starts ticking in the 30s for many people diagnosed a decade later.

Gestational diabetes, which is elevated blood glucose that occurs during pregnancy and resolves after delivery, affects 2 to 10 percent of pregnancies in the United States annually. Women who experience gestational diabetes face a 40 to 60 percent lifetime risk of developing Type 2 diabetes within 5 to 10 years of their delivery, making post-pregnancy screening non-negotiable rather than optional.

Polycystic Ovary Syndrome and Diabetes Risk in Young Women

Polycystic ovary syndrome (PCOS), a hormonal disorder affecting an estimated 1 in 10 women of reproductive age in the United States, is one of the most underrecognized diabetes risk factors in women under 40. PCOS is characterized by irregular menstrual cycles, elevated androgen hormones, and insulin resistance at its core.

Women with PCOS are 4 times more likely to develop Type 2 diabetes than women without the condition, and they often develop it a full decade earlier than the general population. Current ADA guidelines include PCOS as an independent risk factor justifying earlier screening, though implementation in clinical practice remains inconsistent.

Sleep, Stress, and Blood Sugar in Early Adulthood

Chronic sleep deprivation, defined as consistently getting fewer than 6 hours of sleep per night, impairs insulin sensitivity and raises fasting glucose levels through cortisol elevation and disruption of the hormones ghrelin and leptin that regulate hunger and fullness. A meta-analysis published in Diabetologia found that people sleeping fewer than 6 hours nightly had a 28 percent higher risk of developing Type 2 diabetes compared to those sleeping 7 to 8 hours.

Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, releasing cortisol, a stress hormone that raises blood glucose by stimulating the liver to release stored glucose and reducing peripheral insulin sensitivity. Adults in high-stress occupations or life situations who also carry other risk factors may be accumulating metabolic harm invisibly during years when they feel too young to worry about diabetes.

Ages 35 to 44: Where Formal U.S. Screening Begins

The age 35 threshold for diabetes screening exists because the transition from prediabetes to Type 2 diabetes accelerates meaningfully in adults who are overweight or carry metabolic risk factors, giving clinicians a full decade of intervention window that earlier detection unlocks.

The Three Standard Diagnostic Tests Used in the United States

1. Fasting plasma glucose (FPG): Blood is drawn after at least 8 hours of no caloric intake. A result of 100 to 125 mg/dL indicates prediabetes; 126 mg/dL or higher on two separate occasions confirms diabetes.
2. Hemoglobin A1C (HbA1c): This test measures the percentage of hemoglobin (a red blood cell protein) coated with sugar over the prior 2 to 3 months and does not require fasting. An A1C of 5.7 to 6.4 percent indicates prediabetes; 6.5 percent or above confirms diabetes.
3. Oral glucose tolerance test (OGTT): A patient drinks a standardized glucose solution, and blood glucose is measured 2 hours later. A reading of 140 to 199 mg/dL at the 2-hour mark indicates prediabetes; 200 mg/dL or higher indicates diabetes.

Accuracy Limitations Worth Knowing Before You Test

The A1C test can produce falsely low results in people with certain hemoglobin variants, including hemoglobin S (sickle cell trait), hemoglobin C, and hemoglobin E, which are more common in people of African, Mediterranean, and Southeast Asian descent. It can also read falsely low during pregnancy and in people with iron deficiency anemia.

The fasting plasma glucose test is highly sensitive to the completeness of the fasting period. A patient who consumed even a small amount of food or a caloric beverage within the 8-hour window may produce a falsely elevated result. Stress, illness, and certain medications can also transiently elevate fasting glucose without reflecting true prediabetes or diabetes.

When A1C results conflict with symptoms or fasting glucose findings, a second confirmatory test using a different method is recommended before any diagnosis is made.

How Medications Affect Your Test Results

Several commonly prescribed medications can raise or lower blood glucose levels and interfere with accurate screening. Adults in their 30s and 40s prescribed any of the following should inform their provider before glucose testing.

Statins deserve particular attention because they are widely prescribed in adults aged 35 to 64 for cardiovascular risk reduction. A 2010 meta-analysis in The Lancet found that statin use was associated with a 9 percent increased risk of new-onset diabetes. The cardiovascular benefits of statins in appropriate patients substantially outweigh this risk, but providers should monitor glucose in statin users and not attribute borderline results entirely to the medication without further investigation.

Most primary care providers in the United States rely on the FPG or A1C for routine screening because neither requires the extended clinic visit that the OGTT demands. Medicare covers diabetes screening for qualifying beneficiaries at no out-of-pocket cost, and most private insurance plans cover at least one annual screening test under the Affordable Care Act’s (ACA) preventive services mandate, meaning there is typically a $0 copay for eligible adults.

The Pivotal Window: Ages 45 to 64

Adults aged 45 to 64 carry the steepest rate of new Type 2 diabetes diagnoses in the United States, with the CDC estimating that approximately 1 in 5 adults in this age band has diabetes, and a significant portion remains undiagnosed.

Hormonal shifts play a substantial role in this surge. In women, the menopausal transition, typically occurring between ages 45 and 55, is associated with increased central adiposity (belly fat accumulation) and reduced insulin sensitivity. In men, declining testosterone levels after age 40 correlate with higher rates of insulin resistance and metabolic syndrome, a cluster of conditions including elevated blood pressure, high blood sugar, excess waist fat, and abnormal cholesterol levels that together increase heart disease and diabetes risk.

Muscle mass loss, known as sarcopenia, accelerates after age 40 at a rate of roughly 1 to 2 percent per year. Since skeletal muscle is the primary site of glucose uptake, reduced muscle mass directly impairs the body’s capacity to regulate blood sugar, making resistance exercise one of the most biologically targeted interventions available at this life stage.

Men’s Diabetes Risk: A Gap in Awareness

Men in the 45 to 64 age group are significantly less likely than women to pursue preventive health screening, including diabetes testing. Data from the CDC’s Behavioral Risk Factor Surveillance System consistently show that men visit primary care providers less frequently, are less likely to report awareness of prediabetes, and are more likely to be diagnosed with diabetes only after a complication such as a heart attack or foot wound brings them to clinical attention.

Visceral adiposity (fat stored around internal organs rather than under the skin) is more pronounced in men and more metabolically active in terms of generating insulin resistance. A man with a waist circumference exceeding 40 inches carries substantially elevated diabetes risk independent of his overall BMI, making waist measurement a stronger screening signal than weight alone for this group.

Important Data Point: The National Diabetes Prevention Program (NDPP), a CDC-recognized lifestyle change program available at clinics and online throughout the United States, reduces the risk of progressing from prediabetes to Type 2 diabetes by 58 percent in adults who complete it, and by 71 percent in adults over 60.

Risk Factor Load by Age Group

Adults 65 and Older: Managing Elevated Baseline Risk

Nearly 1 in 3 Americans aged 65 and older has diabetes, making this the highest-prevalence age group by a substantial margin, and the complexity of managing diabetes at this stage increases significantly due to compounding age-related physiological changes.

Kidney function declines naturally with age, and diabetes accelerates that decline. Diabetic nephropathy, the kidney damage caused by chronically elevated blood glucose, is the leading cause of kidney failure in the United States, accounting for roughly 44 percent of new cases of end-stage renal disease each year.

For older adults, blood glucose targets and medication choices are often calibrated more conservatively than for younger patients to avoid hypoglycemia (dangerously low blood sugar), which carries its own serious risks including falls, cardiac events, and cognitive impairment.

Late-Onset Type 1 Diabetes and LADA

LADA, or Latent Autoimmune Diabetes in Adults, is a slowly progressing form of autoimmune diabetes that initially resembles Type 2 but is actually driven by the same immune destruction of beta cells seen in Type 1. It accounts for an estimated 5 to 10 percent of all adult diabetes cases and is frequently misclassified as Type 2 because it presents in adulthood without the acute onset typical of childhood Type 1 diabetes.

People with LADA typically respond poorly to oral diabetes medications and progress to insulin dependence within 5 to 10 years of diagnosis. The diagnostic marker is the presence of GAD65 autoantibodies in the blood, which are found in the vast majority of LADA cases but are absent in true Type 2 diabetes.

Any adult diagnosed with apparent Type 2 diabetes who is not overweight, has no strong family history of Type 2, or who fails to respond adequately to oral medications should be considered for GAD65 antibody testing. Sulfonylureas, a class of oral diabetes medications that stimulate the pancreas to produce more insulin, may actually accelerate beta cell destruction in LADA and are generally avoided once the diagnosis is confirmed.

Research consistently shows that people with poorly controlled Type 2 diabetes face a 50 to 65 percent higher risk of developing dementia compared to those without diabetes. Chronic inflammation, blood vessel damage in the brain, and repeated hypoglycemic episodes are all implicated in this relationship.

Individualized Glucose Targets for Older Adults

The ADA stratifies glucose management targets for older adults into three tiers based on health status, rather than applying a single target to everyone over 65.

Tight glucose control in frail older adults increases fall risk, hospitalization for hypoglycemia, and cardiovascular events without meaningfully reducing microvascular complications in people with shorter life expectancy. Screening remains valuable even at 75 and older when life expectancy and functional status support treatment.

Racial and Ethnic Disparities Across Every Age Band

Diabetes risk is not distributed equally across age groups, and racial and ethnic background is one of the strongest independent predictors of who develops diabetes and at what age. American Indian and Alaska Native adults experience the highest rates of diagnosed diabetes of any racial or ethnic group in the United States, with a prevalence of 14.7 percent. Hispanic adults follow at 12.5 percent, non-Hispanic Black adults at 11.7 percent, and non-Hispanic Asian adults at 9.2 percent, compared to 7.5 percent among non-Hispanic White adults.

These disparities appear at younger ages within affected communities. Asian Americans develop Type 2 diabetes at lower BMI thresholds than White adults, leading the ADA to recommend screening Asian Americans beginning at a BMI of 23 kg/m squared rather than the standard 25 kg/m squared cutoff applied to other groups.

Why the Standard BMI Cutoff Misses Risk in Some Populations

The standard BMI thresholds used for diabetes screening were largely derived from studies conducted in predominantly White European populations. Body fat distribution differs meaningfully across racial and ethnic groups in ways that BMI alone does not capture.

South Asian, East Asian, and Southeast Asian adults tend to carry a higher proportion of visceral fat at any given BMI compared to White adults, meaning their metabolic risk is substantially higher at the same measured weight. A South Asian American man with a BMI of 24 may carry the same metabolic risk as a White American man with a BMI of 28, yet only the latter would trigger a diabetes screening conversation under standard guidelines.

For Black Americans, research shows that Black adults have higher rates of insulin resistance at equivalent BMIs compared to White adults, partly driven by differences in fat distribution and partly by the physiological effects of chronic stress exposure. Researchers associate this with weathering, a term describing accelerated biological aging caused by sustained exposure to social and economic adversity, which produces measurable changes in inflammatory markers and metabolic function independent of body weight.

The structural drivers of these disparities are well documented: reduced access to healthcare, higher rates of food insecurity, lower rates of health insurance coverage, and greater exposure to environmental stressors all contribute independently to diabetes risk across every age group.

Gestational Diabetes and the Postpartum Risk Trajectory

Gestational diabetes creates a 40 to 60 percent lifetime risk of Type 2 diabetes for the mother within 5 to 10 years of delivery, making it one of the strongest single risk predictors in women of reproductive age. The standard screening protocol in the United States calls for all pregnant women to be screened between 24 and 28 weeks of gestation using a glucose challenge test, with high-risk women screened at the first prenatal visit.

A diagnosis of gestational diabetes requires medical nutrition therapy (a structured eating plan designed to manage blood glucose through food choices), glucose monitoring, and sometimes insulin or oral medication during the pregnancy itself.

The Child’s Risk After Gestational Diabetes Exposure

The consequences of gestational diabetes extend beyond the mother. Children born to mothers who had gestational diabetes face measurably elevated lifetime diabetes risk themselves, because intrauterine exposure to elevated glucose creates a metabolic environment that programs the developing fetus toward insulin resistance and increased fat storage.

Studies show these children face:

• A 2 to 8 times higher risk of developing obesity in childhood
• Elevated rates of impaired glucose tolerance beginning in adolescence
• Higher rates of Type 2 diabetes in young adulthood compared to children whose mothers did not have gestational diabetes

This intergenerational transmission of diabetes risk makes effective management of gestational diabetes and postpartum follow-up for the mother a two-generation health intervention. After delivery, women who had gestational diabetes should be retested at 4 to 12 weeks postpartum using the OGTT, and then every 1 to 3 years thereafter.

Fewer than 20 percent of women who qualify actually complete postpartum glucose testing, representing a dramatically underutilized prevention window at the exact moment when lifestyle changes are most protective.

What Happens If You Wait Too Long to Get Tested

Type 2 diabetes is frequently asymptomatic in its early stages, meaning many people accumulate organ damage before they receive a diagnosis, and the organs most commonly damaged by chronically elevated blood glucose are the same ones whose dysfunction is most expensive and difficult to treat.

• Eyes: Diabetic retinopathy (damage to the blood vessels of the retina, the light-sensing tissue at the back of the eye) is the leading cause of new blindness among U.S. adults aged 20 to 74.
• Kidneys: Diabetic nephropathy drives nearly 44 percent of all new kidney failure cases in the United States annually.
• Nerves: Diabetic peripheral neuropathy (nerve damage causing numbness, tingling, or pain, usually beginning in the feet) affects up to 50 percent of people with long-standing diabetes.
• Heart: Adults with diabetes are 2 to 4 times more likely to develop cardiovascular disease than adults without the condition.
• Feet: Lower-extremity amputations unrelated to trauma are performed at a rate of roughly 73,000 per year in the United States, with diabetes as the underlying cause in the majority of cases.

The Symptom Timeline Most People Never See Coming

The absence of symptoms in early Type 2 diabetes creates a dangerous false sense of security, particularly for adults in their 40s and 50s who feel generally well. The typical undiagnosed progression unfolds as follows:

1. Years 1 to 5 of elevated glucose: No symptoms. Pancreatic beta cells are overproducing insulin to compensate for insulin resistance. Blood glucose is elevated but not dramatically so.
2. Years 5 to 10: Beta cell exhaustion begins. Fasting glucose creeps higher. A person may notice slightly increased thirst or more frequent nighttime urination but attribute it to dietary habits or aging.
3. Years 8 to 12: Microvascular damage to the kidneys, eyes, and nerves has already begun. The first detectable signs of retinopathy or microalbuminuria (small amounts of protein leaking into urine, an early marker of kidney stress) appear.
4. At diagnosis: Often triggered not by symptoms but by a routine blood panel, a pre-surgical workup, or an acute complication.

This timeline underscores that by the time most people feel sick from Type 2 diabetes, they have already carried it unknowingly for years. Screening intercepts this progression before the damage accumulates.

Turning Your Test Results Into Action

A test result does not exist in isolation; it is the starting point for a structured clinical response. The three most evidence-supported responses to a prediabetes finding are:

1. Structured lifestyle modification: Achieving a 5 to 7 percent reduction in body weight combined with at least 150 minutes of moderate-intensity physical activity per week reduces progression risk by more than half, according to the landmark Diabetes Prevention Program (DPP) randomized controlled trial.
2. Metformin therapy: The medication metformin, a generic drug available in the United States for well under $10 per month at most pharmacies, is recommended by the ADA for adults with prediabetes who are under 60, have a BMI of 35 or higher, or who have a history of gestational diabetes.
3. Repeated monitoring: Even without pharmacological intervention, retesting every 1 to 3 years ensures that any progression is caught promptly and treatment can be escalated before complications develop.

What Happens After a Type 2 Diabetes Diagnosis

Receiving a confirmed Type 2 diabetes diagnosis triggers a structured care pathway that goes beyond a single medication prescription. The standard initial workup includes:

• Comprehensive metabolic panel to assess kidney function, liver function, and electrolytes
• Lipid panel to evaluate cardiovascular risk, since adults with Type 2 diabetes are presumed to carry elevated cardiovascular risk requiring cholesterol management
• Urine albumin-to-creatinine ratio to detect early kidney involvement
• Dilated eye exam by an ophthalmologist or optometrist to establish a retinal baseline
• Foot examination including assessment of sensation, pulses, and skin integrity
• Blood pressure assessment, since the target for adults with diabetes is below 130/80 mmHg
• Referral to diabetes self-management education and support (DSMES), a structured program proven to improve A1C, blood pressure control, and quality of life

First-line medication for most adults with newly diagnosed Type 2 diabetes remains metformin, unless contraindicated. For adults with established cardiovascular disease or high cardiovascular risk, the ADA now recommends adding a GLP-1 receptor agonist (a class of injectable or oral medications that lower blood glucose while also reducing cardiovascular event risk and supporting weight loss) or an SGLT-2 inhibitor (a class of oral medications that lower blood glucose by causing the kidneys to excrete excess glucose in urine while also reducing heart failure hospitalizations and slowing kidney disease progression) regardless of A1C level.

Using Technology to Monitor Between Appointments

Continuous glucose monitors (CGMs), small wearable sensors placed on the skin that measure glucose in the fluid between cells every few minutes, have transformed diabetes management and are increasingly accessible to people with prediabetes and Type 2 diabetes who do not use insulin.

The FDA has cleared several CGM devices for use without a prescription, including the Abbott FreeStyle Libre and the Dexcom Stelo, with retail costs ranging from approximately $30 to $90 per month depending on the device and whether insurance coverage applies.

CGMs provide insight that a quarterly A1C measurement cannot: they reveal glucose variability, meaning how much blood sugar spikes after meals and how quickly it returns to baseline. High glucose variability is an independent cardiovascular risk factor even when average A1C appears acceptable. For adults newly diagnosed or managing prediabetes, CGM data can make the relationship between specific foods, activity timing, sleep, and blood sugar concretely visible in a way that motivates behavioral change more effectively than abstract lab numbers.

The ADA estimates that the average annual medical cost for a person with diagnosed diabetes is $16,752, roughly 2.3 times higher than for a person without the condition. Early identification is the most direct lever available for reducing that financial and health burden.

How to Find Screening Near You

Access to diabetes screening should not depend on having a primary care provider or comprehensive insurance, and multiple pathways exist for adults in the United States to obtain testing regardless of their coverage status.

Free and Low-Cost Testing Options

• Federally Qualified Health Centers (FQHCs): More than 1,400 FQHCs operate across the United States, offering diabetes screening on a sliding fee scale based on income. Patients without insurance may pay $0 to $20 depending on household income.
• Pharmacy-based screening: Major pharmacy chains including CVS, Walgreens, and Rite Aid offer A1C point-of-care testing at many locations for approximately $25 to $55 without insurance, with results available within minutes.
• Community health fairs: The American Diabetes Association, local health departments, and hospital systems regularly host free screening events, particularly during November (American Diabetes Month) and at community events throughout the year.
• Telehealth and at-home testing: Several companies including Everlywell and LetsGetChecked offer mail-in A1C and fasting glucose kits for $50 to $100, completed at home with results reviewed by an affiliated clinician.
• The American Diabetes Association’s risk test: Available free at diabetes.org, this online questionnaire calculates diabetes risk based on age, weight, family history, and activity level in under 2 minutes and is a reasonable first step for anyone uncertain whether formal testing applies to them.

What to Tell Your Doctor to Get Screened

Many adults in the 35 to 44 age range are not offered diabetes screening proactively because providers prioritize acute concerns during brief appointments. Patients who want to be screened can request it directly by saying: “I would like to be screened for prediabetes and Type 2 diabetes, and I understand this is covered under my preventive benefits.”

This framing invokes the ACA’s preventive services provision, which obligates most insurers to cover the test at $0 cost sharing when ordered as preventive care rather than as a diagnostic test for an existing symptom. The distinction between preventive and diagnostic billing matters for what the patient owes, and stating it clearly at the time of the request reduces the chance of the test being coded in a way that generates a copay.

FAQs

What age should I get tested for diabetes?

The ADA recommends that all adults begin diabetes screening at age 45 regardless of weight, and at age 35 if you are overweight or obese with at least one additional risk factor such as a family history or high blood pressure. Children at risk should begin testing at age 10 or at puberty onset, whichever comes first.

At what age does diabetes risk increase the most?

Diabetes risk rises most sharply after age 45, when hormonal changes, muscle mass loss, and accumulated insulin resistance converge in the same biological window. By age 65, nearly 1 in 3 Americans has diabetes, making it the highest-prevalence age group in the country.

Can you get Type 2 diabetes in your 20s or 30s?

Yes. While less common than in older adults, Type 2 diabetes does occur in adults in their 20s and 30s, particularly among those who are overweight, physically inactive, or who have a family history of the condition. Prediabetes can be present for up to 10 years before a formal diagnosis is made.

How often should I be tested for diabetes after age 45?

Adults who receive a normal result at age 45 should be retested every 3 years according to ADA guidelines. If results are borderline or risk factors change, a provider may recommend annual testing to catch progression earlier.

What is prediabetes and how does it relate to age?

Prediabetes is a condition where blood glucose levels are elevated above normal but below the threshold for a Type 2 diabetes diagnosis, specifically an A1C of 5.7 to 6.4 percent or a fasting glucose of 100 to 125 mg/dL. It affects an estimated 96 million U.S. adults and becomes increasingly common after age 35.

Does diabetes risk differ by race at younger ages?

Yes, significantly. Asian Americans develop Type 2 diabetes at lower body weights and are screened at a BMI threshold of 23 kg/m squared rather than the standard 25. American Indian, Black, and Hispanic adults face higher prevalence rates at every age band compared to non-Hispanic White adults, and disparities appear at younger ages within these communities.

Is diabetes testing covered by insurance in the United States?

Under the Affordable Care Act, most private insurers must cover diabetes and prediabetes screening with a $0 out-of-pocket cost for eligible adults when ordered as preventive care. Medicare Part B covers diabetes screening for beneficiaries who meet qualifying criteria at no cost as a preventive benefit.

What is the difference between Type 1 and Type 2 diabetes by age of onset?

Type 1 diabetes is an autoimmune condition most commonly diagnosed in children and young adults, with peak incidence around ages 10 to 14. Type 2 diabetes is driven by insulin resistance and lifestyle factors and most commonly appears after age 35 to 45, though it increasingly occurs in younger people due to rising obesity rates in the United States.

What is gestational diabetes and when does it need to be tested?

Gestational diabetes is elevated blood glucose that develops during pregnancy in a woman who did not have diabetes beforehand. All pregnant women are screened between 24 and 28 weeks of gestation, with high-risk women screened at the first prenatal visit. It affects 2 to 10 percent of pregnancies in the United States each year.

What are the signs of diabetes by age group?

Early Type 2 diabetes is often completely symptom-free, which is why scheduled screening matters regardless of how a person feels. When symptoms do appear they include increased thirst, frequent urination, unexplained fatigue, and blurred vision. Type 1 diabetes in children can present more acutely with rapid weight loss and dangerously elevated blood sugar requiring immediate medical attention.

Can diabetes be prevented if caught early at any age?

Yes. The CDC-recognized National Diabetes Prevention Program demonstrates that structured lifestyle changes reduce the risk of progressing from prediabetes to Type 2 diabetes by 58 percent overall and by 71 percent in adults over 60. Early detection is the necessary first step to accessing that level of risk reduction.

How does menopause affect diabetes risk in women over 45?

The hormonal shifts during menopause, typically occurring between ages 45 and 55, promote increased central fat accumulation and reduced insulin sensitivity, directly raising the risk of developing Type 2 diabetes. Women in this age range benefit from more attentive glucose screening and targeted lifestyle interventions including resistance training to preserve muscle mass and improve insulin sensitivity.

What does a diabetes test actually cost without insurance?

A fasting plasma glucose test typically costs $10 to $30 at a commercial laboratory without insurance. An A1C test ranges from $9 to $50 depending on the provider. Pharmacy chains including CVS and Walgreens offer point-of-care A1C testing for approximately $25 to $55, and free community screening events are common during November (American Diabetes Month).

Why do older adults over 65 face more complications from diabetes?

Adults over 65 with diabetes face compounded risks because age-related declines in kidney function, cardiovascular health, and nerve integrity overlap with diabetes-related damage to the same systems. Hypoglycemia risk also increases with age, requiring individualized glucose targets rather than applying the same control goals used for younger adults.

What is the A1C test and why is it recommended for diabetes screening?

The A1C test measures what percentage of red blood cell hemoglobin is coated with glucose, reflecting average blood sugar over the prior 2 to 3 months. It is widely recommended because it does not require fasting, is reproducible across testing occasions, and provides a longer-term picture of glucose control than a single fasting blood draw.

What is LADA and how does it differ from Type 2 diabetes in adults?

LADA, or Latent Autoimmune Diabetes in Adults, is a slowly progressing form of autoimmune diabetes that resembles Type 2 at onset but is confirmed by the presence of GAD65 autoantibodies in the blood. It affects an estimated 5 to 10 percent of adults diagnosed with apparent Type 2 diabetes and typically progresses to full insulin dependence within 5 to 10 years, much faster than most Type 2 cases.

Does poor sleep increase diabetes risk?

Yes. Adults consistently sleeping fewer than 6 hours per night face a 28 percent higher risk of developing Type 2 diabetes compared to those sleeping 7 to 8 hours, according to published meta-analyses. Sleep deprivation raises cortisol, impairs insulin sensitivity, and disrupts the hunger hormones ghrelin and leptin in ways that promote both weight gain and glucose dysregulation simultaneously.

Can PCOS cause diabetes in young women?

Yes. Polycystic ovary syndrome (PCOS) is driven by insulin resistance at its core and places women at 4 times the risk of developing Type 2 diabetes compared to women without the condition. The ADA lists PCOS as an independent risk factor justifying earlier glucose screening, even in women in their 20s and 30s who would not otherwise meet age or weight thresholds.

What medications can affect my diabetes test results?

Several common medications can raise blood glucose and affect screening accuracy, including corticosteroids such as prednisone, thiazide diuretics such as hydrochlorothiazide, atypical antipsychotics such as olanzapine, and statins such as atorvastatin. Telling your provider about all current medications before testing allows them to interpret results in context or choose a confirmatory test if a result seems inconsistent with your overall health picture.

Where can I get a free or low-cost diabetes screening?

Federally Qualified Health Centers offer sliding-scale screening for $0 to $20 based on income, and more than 1,400 operate across the United States. Pharmacy chains such as CVS and Walgreens offer point-of-care A1C testing for approximately $25 to $55 without insurance. Free community screening events are common during November (American Diabetes Month), and the ADA’s free online risk test at diabetes.org is a useful starting point.

What is the child’s diabetes risk if their mother had gestational diabetes?

Children born to mothers who had gestational diabetes face a 2 to 8 times higher risk of developing obesity in childhood and elevated rates of impaired glucose tolerance beginning in adolescence. This intergenerational transmission makes effective management of gestational diabetes and consistent postpartum follow-up for the mother a two-generation health intervention, not just a maternal one.